TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) stock plunged 14.10% to $1.95 on Thursday, underperforming the broader market and competitors like AbbVie despite a favorable trading session for major indices. This marks the second consecutive day of losses, with the stock closing 33.90% below its 52-week high. Trading volume significantly exceeded the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) plunged 14.10% to $1.95 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.91% to 26,517.93 and the Dow Jones Industrial Average rising 0.14% to 51,564.70.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 33.90% short of its 52-week high of $2.95, which the company reached on January 27th.
The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc. (ABBV) fell 2.14% to $216.49.
Trading volume (69,691) eclipsed its 50-day average volume of 38,683.
Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
06-18-26 1732ET